Letters |

Zafirlukast and Churg-Strauss Syndrome—Reply

Michael E. Wechsler, MD; Jeffrey M. Drazen, MD
JAMA. 1998;279(24):1949-1950. doi:10-1001/pubs.JAMA-ISSN-0098-7484-279-24-jac80011.
Text Size: A A A
Published online


In Reply.— The case report by Drs Katz and Papernik differs from the patients in our article in that their patient developed a similar syndrome but had not been receiving corticosteroids for asthma near the time that zafirlukast therapy was initiated. In our report, we proposed that patients who developed this syndrome did so due to unmasking of an underlying hypereosinophilic syndrome via zafirlukast-induced steroid reduction; however, there are other possible explanations for the cases in our series. This case and some of the patients in our series could represent a reaction to zafirlukast, but the time course of the findings in this patient, 3 months, which is similar to the time course of many of our patients, represents an unusually long time for a drug reaction to develop, and granulomatous angiitis in association with a drug is extremely rare. It is also possible that this patient would have developed the Churg-Strauss syndrome independent of zafirlukast treatment and that prior steroid pulse therapy quelled these manifestations. The patient described could easily have had Churg-Strauss syndrome; perhaps, prior flares that required steroids were augurs of incipient eosinophilic manifestations. This could have been a forme fruste case of Churg-Strauss syndrome.1


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.